Enhanced in vitro activation of immunocompetent cells in healthy individuals being subcutaneously 'vaccinated' with placebo (physiological saline)

Clinical Immunology

Volumn 126, Issue 3, 2008, Pages 322-331

  Klein, Reinhild ^a   Buck, Sandra ^a   Claßen, Karen ^a   Rostock, Matthias ^b   Huber, Roman ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cytokine production; Immunocompetent cells; ; Physiological saline; ; Placebo; ; Recall antigens;

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 5; SODIUM CHLORIDE; TETANUS TOXOID; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CELL ACTIVATION; CELL ISOLATION; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IN VITRO STUDY; INTERFERON PRODUCTION; MACROPHAGE; MALE; MAST CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; TH1 CELL; TH2 CELL; VACCINATION;

ADULT; ANTIGENS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH; HUMANS; IMMUNOCOMPETENCE; INJECTIONS, SUBCUTANEOUS; MACROPHAGES; MALE; PLACEBO EFFECT; SODIUM CHLORIDE; T-LYMPHOCYTES; VACCINATION;

EID: 38949164744     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.09.007     Document Type: Article

References (51)

1. Kleinman A., Guess H.A., and Wilentz J.S. An overview. In: Guess H.A., Kleinman A., Kusek J.W., and Engel L.W. (Eds). The Science of the Placebo: Towards an Interdisciplinary Research Agenda (2002), BMJ, London 1-32
2. Benedetti F., Mayberg H.S., Wager T.D., and Stohler C.S. Neurobiological mechanisms of the placebo effect. J. Neurosci. 25 (2005) 10390-10402
3. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., and Abrams M. Changes in brain function of depressed subjects during treatment with placebo. Am. J. Psychiatr. 159 (2002) 122-129
4. Mayberg H.S., Silva A.J., Brannan S.K., Tekell J.L., Mahurin R.K., McGinnis S., and Jerabek P.A. The functional neuroanatomy of the placebo effect. Am. J. Psychiatr. 159 (2002) 728-737
5. De la Fuente-Fernandez R., Schulzer M., and Stoessl A.J. The placebo effect in neurological disorders. Lancet Neurol. 1 (2002) 85-91
6. Pollo A., Amanzio M., Arslanian A., Casadio C., Maggi G., and Benedetti F. Response expectancies in placebo analgesia and their clinical relevance. Pain 93 (2001) 77-84
7. Ader R. Conditional immunomodulation; research needs and directions. Brain Behav. Immun. 17 (2003) S51-S57
8. Goebel M.U., Trebst A.E., Steiner J., Xie Y.E., Exton M.S., Frede S., Canbay A.E., Michel M.C., Heemann U., and Schedlowski M. Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 16 (2002) 1869-1873
9. Huber R., Klein R., Berg P.A., Lüdtke R., and Werner M. Effects of a lectin- and viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects. J. Altern. Complement. Med. 8 (2002) 857-866
10. Huber R., Claßen K., Werner M., and Klein R. In vitro immunoreactivity towards lectin-rich or viscotoxin-rich mistletoe extracts applied to healthy individuals in vivo: a randomised double-blinded placebo controlled study. Arzneim.-Forsch./Drug Res. 56 (2006) 447-456
11. Huber R., Rostock M., Goedl R., Lüdtke R., Urech K., Buck S., and Klein R. Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects. Eur. J. Med. Res. 10 (2005) 411-418
12. Barth H., Klein K., Börtlein A., Guseo A., Berg P.A., Wiethölter H., and Klein R. Analysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced TH1, relapsing-remitting course with enhanced TH0 reactivity. J. Neuroimmunol. 133 (2002) 175-183
13. Barth H., Berg P.A., and Klein R. Methods for the in vitro determination of an individual disposition towards TH1- or TH2-reactivity by the application of appropriate stimulatory antigens. Clin. Exp. Immunol. 134 (2003) 78-85
14. Klein R., Claßen K., Berg P.A., Lüdtke R., Werner M., and Huber R. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals. Eur. J. Med. Res. 7 (2002) 155-163
15. Huber R., Klein R., Lüdtke R., and Werner M. Häufigkeit prippaler Infekte bei Gesunden unter Gabe eines lektinreichen und eines lektinarmen Mistelpräparats im Rahmen einer randimisierten, doppelblinden, placebokontrollierten Studie. Forsch. Komplementärmed. Klass. Naturheilkd. 8 (2001) 354-358
16. DelPrete G.F., De Carli M., Mastromauro C., et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profiles of cytokine production. J. Clin. Invest. 88 (1991) 346-350
17. ElGhazali G.E.B., Pauli S., Andersson G., et al. Number of interleukin-4- and interferon-G-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur. J. Immunol. 23 (1993) 2740-2745
18. Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Statist. 6 (1979) 65-70
19. Miller F.G., Wendler D., and Swartzman L.C. Deception in research on the placebo effect. PLoS Med. 2 (2005) 853-859
20. Chvetzoff G., and Tannock I.F. Placebo effects in oncology. J. Natl. Cancer Inst. 95 (2003) 19-29
21. Hrobjatsson A., and Gotzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N. Engl. J. Med. 344 (2001) 1594-1602
22. Blalock J.E. The immune system as the sixth sense. J. Int. Med. 257 (2005) 126-138
23. Stewart-Williams S. The placebo-puzzle: putting together the pieces. Health Psychol. 23 (2004) 198-206
24. Haas H.S., and Schauenstein K. Neuroimmunomodulation via limbic structures - the neuroanatomy of psychoneuroimmunology. Prog. Neurobiol. 51 (1997) 195-222
25. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune mediated inflammation. N. Engl. J. Med 332 (1995) 1351-1362
26. Elenkov I.J., and Chrousos G.P. Stress hormones, Th1/Th2 patterns,pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol. Metab. 10 (1999) 359-368
27. Matalka K.Z. Neuroendocrine and cytokines-induced responses to minutes, hours, and days of mental stress. Neuro Endocrinol. Lett. 24 (2003) 283-292
28. Berk L.S., Felte D.L., Tan S.A., Bittman B.B., and Westengard J. Modulation of neuroimmune parameters during the eustress of humor-associated mirthful laughter. Ther. Health Med. Altern. 7 (2001) 62-72
29. Elenkov I.J., Iezzoni D.G., Daly A., Harris A.G., and Chrousos G.P. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12 (2005) 255-269
30. Hayney M.S., Love G.D., Buck J.M., Ryff C.D., Singer B., and Muller D. The association between psychosocial factors and vaccine-induced cytokine production. Vaccine 21 (2003) 2428-2432
31. Sinclar V.G., and Scroggie J. Effects of a cognitive-behavioral program for women with multiple sclerosis. J. Neurosci. Nurs. 37 (2005) 249-257
32. Rosenkranz M.A., Jackson D.C., Dalton K.M., Dolski I., Ryff C.D., Singer B.H., Muller D., Kalin N.H., and Davidson R.J. Affective style and in vivo immune response: neurobehavioral mechanisms. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11148-11152
33. Payne L.C., Weigent D.A., and Blalock J.E. Induction of pituitary sensitivity to interleukin-1: a new function for corticotropin-releasing hormone. Biochem. Biophys. Res. Commun. 198 (2006) 480-484
34. Ito N. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal (HPA) axis and synthesize cortisol. FASEB J. 19 (2005) 1332-1334
35. Slominski A. Propriomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett. 374 (1995) 113-116
36. Cao J., Papadopoulou N., Kempuraj D., Boucher W.S., Sugimoto K., Cetrulo C.L., and Theoharides T.C. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J. Immunol. 174 (2005) 7665-7675
37. Paus R., Theoharides T.C., and Arck P.C. Neuroimmuniendocrine circuitry of the 'brain-skin connection'. Trends Immunol. 27 (2006) 32-39
38. Maurer M. What is the physiological function of mast cells?. Exp. Dermatol. 12 (2003) 886-910
39. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 176 (2006) 2238-2248
40. Luger T.A. Neuromediators - a crucial component of the skin immune system. J. Dermatol. Sci. 30 (2002) 87-93
41. Gallowitsch-Puerta M., and Tracey K.J. Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine a7 receptor. Ann. N. Y. Acad. Sci. 1062 (2005) 209-219
42. Libert C. A nervous connection. Nature 421 (2003) 328-329
43. Jeong H.J., Kim B.S., Oh J.G., Kim K.S., and Kim H.M. Regulatory effect of cytokine production in asthma patients by SOOJI (Koryo Hand Acupuncture Therapy). Immunopharmacol. Immunotoxicol. 24 (2002) 265-274
44. Joos S., Schott C., Zou H., Daniel V., and Martin E. Immunomodulatory effects of acupuncture in the treatment of allergic asthma: a randomized controlled study. J. Altern. Complement Med. 6 (2000) 519-525
45. Kou W., Bell J.D., Gareus I., Pacheco-Lopez G., Goebel M.U., Spahn G., Stratmann M., Janssen O.E., Schedlowski M., and Dobos G.J. Repeated acupuncture treatment affects leukocyte circulation in healthy younf male subjects: a randomized single-blind two period crossover study. Brain Behav. Immun. 19 (2005) 318-324
46. Mori H., Nishijo K., Kawamura H., and Abo T. Unique immunomodulation by electro-acupuncture in humans possibly via stimulation of the autonomic nervous system. Neurosci. Lett. 320 (2002) 21-24
47. Ho C.S., Lopez J.A., Vuckovic S., Pyke C.M., Hockey R.L., and Hart D.N. Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts. Blood 98 (2001) 140-145
48. Manome H., Aiba S., and Tagami H. Simple chemicals can induce maturation and apoptosis of dendritic cells. Immunology 98 (1999) 481-490
49. Watari E., Shimizu M., and Takahashi H. Langerhans cells stimulated by mechanical stress are susceptible to measles virus infection. Intervirology 48 (2005) 145-152
50. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006) 24-31
51. Schauenstein K., Rinner I., Felsner P., Stevenson R., Haas H.S., and Liebmann P. Mens sana in corpore sano - and vice versa. The role of the autonomic nervous system in the immune-neuroendocrine dialogue. Int. J. Hyg. Environ. Health 204 (2001) 75-79